Key Responsibilities:

• Co-leads with the CSL the clinical trial team in collaboration with the Clinical Operations Program Head (COPH), delivery of multiple complex global studies and promotes learning, sharing, consistent performance, and operational excellence through an agile mindset, agile principles, and a team of team’s model
• Guides planning and decision making at the study level and delivers assigned clinical study/studies per the Operational Execution Plan (OEP) and clinical study protocol
• In collaboration with regulatory writing and clinical development, promotes operational excellence in the development of global clinical study protocol(s), by translating the approved study concept sheet(s) into efficient, high quality, executable clinical protocols, and study-related documents
• Create effective CTT dynamics and achieve on performance, prioritization, and communication in close collaboration with CTT sub-team leaders
• Proactive risk management and inspection readiness. Ensures systems are maintained with up-to-date study status, risks, and issues
• Responsible for developing clinical study timelines in collaboration with the Clinical Operations Program Head (COPH), and overseeing assigned study budgets
• Oversees study recruitment and responsible for activating mitigation strategies in collaboration with the SSO Clinical Program Managers (CPMs)
• Ensures proper handling of all study close out activities including, but not limited to, site close out, final drug accountability, and audit readiness of Trial Master File documentation
• Promotes operational excellence and contributes to the development of Clinical Study Reports; reporting of clinical study results, and internal/external publications, when appropriate
• Achieves excellence in study operations and management through process improvement in collaboration with the Study Leadership Community Lead and GCO Process, Training, and Compliance (PTC)

Essential Requirements:

• Education: Bachelor’s degree in life sciences/healthcare (or clinically relevant degree) is required. Advanced degree is strongly preferred.
• ≥ 7 years of recent involvement in clinical research or drug development in an academic or industry environment spanning clinical activities in Phases I through IV studies of medium to highly complexity
• ≥ 3-5 years of recent contribution to and accomplishment in all aspects of conducting clinical studies of medium to highly complexity and of high priority for Novartis (e.g., planning, executing, reporting, and publishing) in a global/matrix environment in pharmaceutical industry or a contract research organization, including expert knowledge of international standards (GCP/ICH), health authorities (FDA/EMA), local/National Health Authorities regulations
• Management of virtual teams. Proven ability and strong experience leading teams and building capabilities
• Experience in developing effective working relationships with internal and external stakeholders
• Excellent communicator and presenter (oral and written); ability to communicate at all levels
• Excellent negotiation and conflict resolution skills and enterprise mindset
• Strong project management skills and demonstrated ability to meet timeline
• Proven track record in study operations process improvement(s)

The pay range for this position at commencement of employment is expected to be between $185,500 and $344,500/year; however, while salary ranges are effective from 1/1/25 through 12/31/25, fluctuations in the job market may necessitate adjustments to pay ranges during this period. Further, final pay determinations will depend on various factors, including, but not limited to geographical location, experience level, knowledge, skills and abilities. The total compensation package for this position may also include other elements, including a sign-on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits (including 401(k) eligibility and various paid time off benefits, such as vacation, sick time, and parental leave), dependent on the position offered. Details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.